Ellwood PM. Shattuck lecture—outcomes management. A technology of patient experience. N Engl J Med. 1988;318(23):1549–1556. doi:10.1056/NEJM198806093182327
Porter M, Lee TH. The strategy that will fix health care. Harvard Business Review. October 2013. Accessed September 16, 2021. https://hbr.org/2013/10/the-strategy-that-will-fix-health-care
Clancy CM, Eisenberg JM. Outcomes research: measuring the end results of health care. Science. 1998;282(5387):245–246. doi:10.1126/science.282.5387.245
US pet ownership and demographic sourcebook. 2017–2018 edition. AVMA. Accessed September 16, 2021. https://www.avma.org/sites/default/files/resources/AVMA-Pet-Demographics-Executive-Summary.pdf
Pet industry market size, trends & ownership statistics. American Pet Products Association. Accessed May 6, 2021. https://www.americanpetproducts.org/press_industrytrends.asp
Friedman E, Krause-Parello CA. Companion animals and human health: benefits, challenges, and the road ahead for human-animal interaction. Rev Sci Tech. 2018;37(1):71–82. doi:10.20506/rst.37.1.2741
Beetz A, Uvnäs-Moberg K, Julius H, Kotrschal K. Psychosocial and psychophysiological effects of human-animal interactions: the possible role of oxytocin. Front Psychol. 2012;3:234. doi:10.3389/fpsyg.2012.00234
Morgan L, Protopopova A, Dupont Birker RI, et al. Human-dog relationships during the COVID-19 pandemic: booming dog adoption during social isolation. Humanit Soc Sci Commun. 2020;7:155. doi:10.1057/s41599–020–00649-x
Ratschen E, Shoesmith E, Shahab L, et al. Human-animal relationships and interactions during the Covid-19 lockdown phase in the UK: investigating links with mental health and loneliness. PLoS One. 2020;15(9):e0239397. doi:10.1371/journal.pone.0239397
Are pet adoptions really skyrocketing? AVMA. Accessed May 6, 2021. https://www.avma.org/javma-news/2021–01–15/are-pet-adoptions-really-skyrocketing
Burgos Cáceres S. The roles of veterinarians in meeting the challenges of health and welfare of livestock and global food security. Vet Res Forum. 2012;3(3):155–157.
The roles of veterinarians in meeting the challenges of health and welfare of livestock and global food security. Animal Production and Health. Food and Agriculture Organization of the United Nations (FAO). Accessed May 5, 2021. www.fao.org/ag/againfo/home/en/news_archive/2011_The_roles_of_veterinarians.html
Lenarduzzi R, Sheppard GA, Slater MR. Factors influencing the choice of a career in food-animal practice among recent graduates and current students of Texas A&M University, College of Veterinary Medicine. J Vet Med Educ. 2009;36(1):7–15. doi:10.3138/jvme.36.1.7
Rural veterinary care. AVMA. Accessed June 3, 2021. https://www.avma.org/advocacy/rural-veterinary-care
Stull JW, Shelby JA, Bonnett BN, et al. Barriers and next steps to providing a spectrum of effective health care to companion animals. J Am Vet Med Assoc. 2018;253(11):1386–1389. doi:10.2460/javma.253.11.1386
Volk JO, Felsted KE, Thomas JG, Siren CW. Executive summary of the Bayer veterinary care usage study. J Am Vet Med Assoc. 2011;238(10):1275–1282. doi:10.2460/javma.238.10.1275
Kipperman BS, Kass PH, Rishniw M. Factors that influence small animal veterinarians’ opinions and actions regarding cost of care and effects of economic limitations on patient care and outcome and professional career satisfaction and burnout. J Am Vet Med Assoc. 2017;250(7):785–794. doi:10.2460/javma.250.7.785
Coe JB, Adams CL, Bonnett BN. A focus group study of veterinarians’ and pet owners’ perceptions of the monetary aspects of veterinary care. J Am Vet Med Assoc. 2007;231(10):1510–1518. doi:10.2460/javma.231.10.1510
Jensen KL, English BC, Menard RJ, Holland RE. Livestock producers’ views on accessing food-animal veterinary services: implications for student recruitment, training, and practice management. J Vet Med Educ. 2009;36(1):30–38. doi:10.3138/jvme.36.1.30
Pires AFA, Peterson A, Baron JN, Adams R, Martínez-López B, Moore D. Small-scale and backyard livestock owners needs assessment in the western United States. PLoS One. 2019;14(2):e0212372. doi:10.1371/journal.pone.0212372
Jefford M, Stockler MR, Tattersall MHN. Outcomes research: what is it and why does it matter? Intern Med J. 2003;33(3):110–118. doi:10.1046/j.1445-5994.2003.00302.x
Karakiewicz PI, Briganti A, Chun FKH, Valiquette L. Outcomes research: a methodologic review. Eur Urol. 2006;50(2):218–224. doi:10.1016/j.eururo.2006.05.009
Poulsen Nautrup B, Van Vlaenderen I. Cost-effectiveness of Pimobendan versus Benazepril in acquired myxomatous mitral valve disease in dogs: an adaptation to Switzerland. Value Health. 2009;12(3):A62. Abstract.
Van Vlaenderen I, Nautrup BP, Gasper SM. Estimation of the clinical and economic consequences of non-compliance with antimicrobial treatment of canine skin infections. Prev Vet Med. 2011;99(2-4):201–210. doi:10.1016/j.prevetmed.2011.01.006
Reid J, Wiseman-Orr ML, Scott EM, Nolan AM. Development, validation and reliability of a web-based questionnaire to measure health-related quality of life in dogs. J Small Anim Pract. 2013;54(5):227–233. doi:10.1111/jsap.12059
Wright A, Amodie D, Cernicchiaro N, Lascelles B, Pavlock A. Diagnosis and treatment rates of osteoarthritis in dogs using a health risk assessment (HRA) or health questionnaire for osteoarthritis in general veterinary practice. Value Health. 2019;22(2):S387. doi:10.1016/j.jval.2019.04.1886
Tonsor GT, Schroeder TC. Market impacts of E. coli vaccination in US feedlot cattle. Agric Food Econ. 2015;3(7):1–15. doi:10.1186/s40100-014-0021-2
Benedictus A, Hogeveen H, Berends BR. The price of the precautionary principle: cost-effectiveness of BSE intervention strategies in the Netherlands. Prev Vet Med. 2009;89(3-4):212–222. doi:10.1016/j.prevetmed.2009.03.001
Suijkerbuijk AWM, van Gils PF, Bonačić Marinović AA, et al. The design of a social cost-benefit analysis of preventive interventions for toxoplasmosis: an example of the One Health approach. Zoonoses Public Health. 2018;65(1):185–194. doi:10.1111/zph.12417
Mangen MJJ, de Wit GA, Havelaar AH. Economic analysis of Campylobacter control in the Dutch broiler meat chain. Agribusiness. 2007;23(2):173–192. doi:10.1002/agr.20123
Barratt AS, Rich KM, Eze JI, Porphyre T, Gunn GJ, Stott AW. Framework for estimating indirect costs in animal health using time series analysis. Front Vet Sci. 2019;6(120):190. doi:10.3389/fvets.2019.00190
McReynolds SW, Sanderson MW, Reeves A, Hill AE. Modeling the impact of vaccination control strategies of a foot and mouth disease outbreak in the Central United States. Prev Vet Med. 2014;117(3–4):487–504. doi:10.1016/j.prevetmed.2014.10.005
Schroeder TC, Pendell DL, Sanderson MW, McReynolds S. Economic impact of alternative FMD emergency vaccination strategies in the Midwestern United States. J Agric Appl Econ. 2015;47(1):47–76. doi:10.1017/aae.2014.5
Codman EA. The product of a hospital. 1914. Arch Pathol Lab Med. 1990;114(11):1106–1111.
Codman EA. The classic: a study in hospital efficiency: as demonstrated by the case report of first five years of private hospital. Clin Orthop Relat Res. 2013;471(6):1778–1783. doi:10.1007/s11999-012-2751-3
Donabedian A. Evaluating the quality of medical care. Milbank Q. 2005;83(4):691–729. doi:10.1111/j.1468-0009.2005.00397.x
Cochrane AL. Archie Cochrane in his own words. Selections arranged from his 1972 introduction to “Effectiveness and efficiency: random reflections on the health services”. Control Clin Trials. 1989;10(4):428–433. doi:10.1016/0197-2456(89)90008-1
Mission O. The Professional Society for Health Economics and Outcomes Research. Accessed September 16, 2021. https://www.ispor.org/about/our-mission.
Story O. Patient-Centered Outcomes Research Institute. Accessed September 16, 2021. https://www.pcori.org/about-us/our-story
Director’s Welcome. Center for Outcomes Research & Evaluation (CORE). Yale School of Medicine. Accessed September 16, 2021. https://medicine.yale.edu/core/about/
Center for Health Services and Outcomes Research. Johns Hopkins Bloomberg School of Public Health. Accessed May 7, 2021. www.jhsph.edu/research/centers-and-institutes/health-services-outcomes-research/
Krumholz HM. Outcomes research: generating evidence for best practice and policies. Circulation. 2008;118(3):309–318. doi:10.1161/CIRCULATIONAHA.107.690917
Spertus J, Lozada L, Jones P. Sustaining and disseminating the evidence. Abstract in: Proceedings of the Translational Medicine Meeting. BioNexus KC; 2016.
Karcher H, Fu S, Efthimiou O, Schneeweiss S, Abenhaim L. A practical guide to adding patient heterogeneity into phase III trials: results from IMI GetReal WP2. Abstract in: Proceedings of the International Society for Health Economics and Outcomes Research, Annual European Congress. Professional International Society for Health Economics and Outcomes Research; 2015.
Karcher H, Nordon C, Neumann M, et al. Methods to evaluate real-world effectiveness in pre-authorization trials: a systematic literature review for IMI GetReal WP2. Abstract in: Proceedings of the Health Technology Assessment International Annual Meeting. Health Technology Assessment International; 2015.
Shaw APM, Rushton J, Roth F, Torgerson PR. DALYs, dollars and dogs: how best to analyse the economics of controlling zoonoses. Rev Sci Tech. 2017;36(1):147–161. doi:10.20506/rst.36.1.2618
Torgerson PR, Rüegg S, Devleesschauwer B, et al. zDALY: an adjusted indicator to estimate the burden of zoonotic diseases. One Health. 2017;5:40–45. doi:10.1016/j.onehlt.2017.11.003
Lavan RP. Development and validation of a survey for quality of life assessment by owners of healthy dogs. Vet J. 2013;197(3):578–582. doi:10.1016/j.tvjl.2013.03.021
Belshaw Z, Asher L, Harvey ND, Dean RS. Quality of life assessment in domestic dogs: an evidence-based rapid review. Vet J. 2015;206(2):203–212. doi:10.1016/j.tvjl.2015.07.016
Mwacalimba KK, Contadini FM, Spofford N, et al. Owner and veterinarian perceptions about use of a canine quality of life survey in primary care settings. Front Vet Sci. 2020;7:89. doi:10.3389/fvets.2020.00089
Parker RA, Yeates JW. Assessment of quality of life in equine patients. Equine Vet J. 2012;44(2):244–249. doi:10.1111/j.2042-3306.2012.00583.x
Cook JL. Canine orthopedic outcome measures program: where are we now? Vet Surg. 2014;43(3):229–231. doi:10.1111/j.1532-950X.2014.12167.x
Giuffrida MA, Brown DC, Ellenberg SS, Farrar JT. Development and psychometric testing of the Canine Owner-Reported Quality of Life questionnaire, an instrument designed to measure quality of life in dogs with cancer. J Am Vet Med Assoc. 2018;252(9):1073–1083. doi:10.2460/javma.252.9.1073
Bowen J, Garcia E, Darder P, Arguelles J, Fatjo J. The effects of the Spanish COVID-19 lockdown on people, their pets, and the human-animal bond. J Vet Behav. 2020;40:75–91. doi:10.1016/j.jveb.2020.05.013
Piotti P, Karagiannis C, Satchell L, et al. Use of the Milan pet quality of life instrument (MPQL) to measure pets’ quality of life during COVID-19. Animals (Basel). 2021;11:1336. doi:10.3390/ani11051336
Wilson SJ, Ward MP, Garner MG. A framework for assessing the intangible impacts of emergency animal disease. Prev Vet Med. 2013;111:194–199. doi:10.1016/j.prevetmed.2013.05.003
Pantaleon L. Why measuring outcomes is important in health care. J Vet Intern Med. 2019;33:356–362. doi:10.1111/jvim.15458
Bouwer A. Analysis of survey data for learning effectiveness evaluation of a talent management program for dairies and feedlots. Abstract in: Proceedings of the International Society for Health Economics and Outcomes Research, Annual International Meeting. Professional International Society for Health Economics and Outcomes Research; 2015.
Bouwer A, Holland R, Walter S. Evaluation of audit scoring consistency in a comprehensive feedlot management system and correlation with feedyard performance based on average daily gain and dry feed conversation in 11 US feedlots. Abstract in: Proceedings of the International Society for Health Economics and Outcomes Research, Annual International Meeting. Professional International Society for Health Economics and Outcomes Research; 2015.
Falzon LC, Lechner I, Chantziaras I, et al. Quantitative outcomes of a one health approach to study global health challenges. EcoHealth. 2018;15(1):209–227. doi:10.1007/s10393-017-1310-5
Vellinga TV, de Haan MHA, Schils RLM, Evers A, van den Pol–van Dasselaar A. Implementation of GHG mitigation on intensive dairy farms: farmers’ preferences and variation in cost effectiveness. Livest Sci. 2011;137:185–195. doi:10.1016/j.livsci.2010.11.005
Wright A, Russo S, DiFranco B, Gasper S, Amodie D. Client acceptance trial with injectable cefovecin sodium in dogs as a first line of treatment for superficial pyoderma, wounds, and abscesses caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis group G. Abstract in: Proceedings of the International Society for Health Economics and Outcomes Research, Annual International Meeting. Professional International Society for Health Economics and Outcomes Research; 2015.
Widmar NO, Bir C, Slipchenko N, Wolf C, Hansen C, Ouedraogo F. Online procurement of pet supplies and willingness to pay for veterinary telemedicine. Prev Vet Med. 2020;181:105073. doi:10.1016/j.prevetmed.2020.105073
Depoorter P, Van Huffel X, Diricks H, et al. Measuring general animal health status: development of an animal health barometer. Prev Vet Med. 2015;118(4):341–350. doi:10.1016/j.prevetmed.2014.12.008
Poulsen Nautrup B, van Vlaenderen IV, Wright A, Holland R, Gasper S. Health and economic benefits of vaccinating horses against West Nile Virus in the USA. Abstract in: Proceedings of the 13th World Equine Veterinary Association Congress. World Equine Veterinary Association; 2013.
Abell KM, Theurer ME, Larson RL, White BJ, Apley M. A mixed treatment comparison meta-analysis of metaphylaxis treatments for bovine respiratory disease in beef cattle. J Anim Sci. 2017;95(2):626–635. doi:10.2527/jas.2016.1062
Cull CA, Paddock ZD, Nagaraja TG, Bello NM, Babcock AH, Renter DG. Efficacy of a vaccine and a direct-fed microbial against fecal shedding of Escherichia coli O157:H7 in a randomized pen-level field trial of commercial feedlot cattle. Vaccine. 2012;30(43):6210–6215. doi:10.1016/j.vaccine.2012.05.080
Cull CA, Renter DG, Bello NM, Ives SE, Babcock AH. Performance and carcass characteristics of commercial feedlot cattle from a study of vaccine and direct-fed microbial effects on Escherichia coli O157:H7 fecal shedding. J Anim Sci. 2015;93(6):3144–3151. doi:10.2527/jas.2015-8924
Dennis EJ, Schroeder TC, Renter DG, Pendell DL. Value of arrival metaphylaxis in US cattle industry. 2018. J Agric Resour Econ. 2018;43(2):233–250. doi:10.22004/ag.econ.273448
O’Connor AM, Yuan C, Cullen JN, Coetzee JF, da Silva N, Wang C. A mixed treatment meta-analysis of antibiotic treatment options for bovine respiratory disease—an update. Prev Vet Med. 2016;132:130–139. doi:10.1016/j.prevetmed.2016.07.003
Poulsen Nautrup B, Van Vlaenderen I, Decker M, Cleale RM. Antimicrobial drug use for control and treatment of bovine respiratory disease in US feedlot cattle: a meta-analysis of comparative studies versus tulathromycin. Bovine Pract. 2017;51(1):1–13. doi:10.21423/bovine-vol51no1p1-13
Roth F, Zinsstag J, Orkhon D, et al. Human health benefits from livestock vaccination for brucellosis: case study. Bull World Health Organ. 2003;81(12):867–876.
Babo Martins S, Rushton J. Cost-effectiveness analysis: adding value to assessment of animal health, welfare and production. Rev Sci Tech. 2014;33(3):681–689. doi:10.20506/rst.33.3.2312
Bergevoet RH, van Schaik G, Veling J, Backus GBC, Franken P. Economic and epidemiological evaluation of Salmonella control in Dutch dairy herds. Prev Vet Med. 2009;89(1-2):1–7. doi:10.1016/j.prevetmed.2008.12.007
Lawson LG, Jensen JD, Christiansen P, Lund M. Cost-effectiveness of Salmonella reduction in Danish abattoirs. Int J Food Microbiol. 2009;134(1-2):126–132. doi:10.1016/j.ijfoodmicro.2009.03.024
Simons R, Hill A, de Souza Monteiro D, Fraser R, Cook A. A cost-effectiveness analysis for Salmonella interventions in the British pig meat production chain. Abstract in: Proceedings of the International Symposium on the Epidemiology and Control of Biological, Chemical and Physical Hazards in the Pork Chain. MCI Deutschland GmbH; 2009.
Pillars RB, Grooms DL, Wolf CA, Kaneene JB. Economic evaluation of Johne’s disease control programs implemented on six Michigan dairy farms. Prev Vet Med. 2009;90(3-4):223–232. doi:10.1016/j.prevetmed.2009.04.009
Martínez-López B, Carpenter TE, Sánchez-Vizcaíno JM. Risk assessment and cost-effectiveness analysis of Aujeszky’s disease virus introduction through breeding and fattening pig movements into Spain. Prev Vet Med. 2009;90(1-2):10–16. doi:10.1016/j.prevetmed.2009.03.004
De Vos CJ, Saatkamp HW, Huirne RB. Cost-effectiveness of measures to prevent classical swine fever introduction into the Netherlands. Prev Vet Med. 2005;70(3-4):235–256. doi:10.1016/j.prevetmed.2005.04.001
Knight-Jones TJ, Hauser R, Matthes D, Stärk KDC. Evaluation of effectiveness and efficiency of wild bird surveillance for avian influenza. Vet Res. 2010;41(4):50. doi:10.1051/vetres/2010023
Hadorn D, Racloz V, Schwermer H, Stärk KDC. Establishing a cost-effective national surveillance system for Bluetongue using scenario tree modelling. Vet Res. 2009;40(6):1–14. doi:10.1051/vetres/2009040
Regula G, Lo Fo Wong DM, Ledergerber U, et al. Evaluation of an antimicrobial resistance monitoring program for Campylobacter in poultry by simulation. Prev Vet Med. 2005;70(1-2):29–43. doi:10.1016/j.prevetmed.2005.02.017
Telemedicine. AVMA. Accessed August 6, 2021. https://www.avma.org/resources-tools/avma-policies/telemedicine
Cleaveland S, Kaare M, Knobel D, Laurenson MK. Canine vaccination—providing broader benefits for disease control. Vet Microbiol. 2006;5(117-1):43–50. doi:10.1016/j.vetmic.2006.04.009
Kaare M, Lembo T, Hampson K, et al. Rabies control in rural Africa: evaluating strategies for effective domestic dog vaccination. Vaccine. 2009;27(1):152–160. doi:10.1016/j.vaccine.2008.09.054
Beyene TJ, Fitzpatrick M, Galvani AP, et al. Impact of One-Health framework on vaccination cost-effectiveness: a case study of rabies in Ethiopia. One Health. 2019;8:100103. doi:10.1016/j.onehlt.2019.100103
Okello WO, Okello AL, Inthavong P, et al. Improved methods to capture the total societal benefits of zoonotic disease control: demonstrating the cost-effectiveness of an integrated control programme for Taenia solium, soil transmitted helminths and classical swine fever in northern Lao PDR. PLoS Negl Trop Dis. 2018;12(9):e0006782. doi:10.1371/journal.pntd.0006782
Taylor D. The pharmaceutical industry and the future of drug development. In: Hester RE, Harrison RM, eds. Pharmaceuticals in the Environment. Royal Society of Chemistry; 2015:1–33. doi:10.1039/9781782622345–00001
Sullivan SD, Manuskopf JA, Augustovski F, et al. Budget impact analysis—principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value Health. 2014;17(1):5–14. doi:10.1016/j.jval.2013.08.2291
Sørensen J, Andersen LS. The case of tumour necrosis factor-α inhibitors in the treatment of rheumatoid arthritis—a budget impact analysis. Pharmacoeconomics. 2005;23(3):289–298. doi:10.2165/00019053-200523030-00008
Nuijten MJC, Rutten F. Combining a budgetary-impact analysis and a cost-effectiveness analysis using decision-analytic modelling techniques. Pharmacoeconomics. 2002;20(12):855–867. doi:10.2165/00019053-200220120-00006
National Institute for Health and Care Excellence (NICE). Accessed May 7, 2021. https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/chte-methods-consultation
Basu A. Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care. J Health Econ. 2011;30(3):549–559. doi:10.1016/j.jhealeco.2011.03.004
Karcher H, Bradbury C, Mozaffari E, et al. Drivers of effectiveness for informed outcomes-based agreements. Abstract in: Proceedings of the International Society for Health Economics and Outcomes Research, Annual International Meeting. Professional International Society for Health Economics and Outcomes Research; 2016.
Top10 HEOR trends. International Society for Pharmacoeconomics and Outcomes Research. Accessed May 7, 2020. https://www.ispor.org/docs/default-source/heor-resources/2020-top-10-heor-trendsv-online_00120191219.pdf?sfvrsn=9eebcb74_0
Industry data. North American Pet Health Insurance Association (NAPHIA). Accessed May 7, 2021. https://naphia.org/industry-data/
Ross K. Pet insurance for all: Sweden’s experience. Accessed August 6, 2021. https://news.vin.com/default.aspx?pid=210&Id=9305364
Mills G. New highs for pet insurance market. Vet Rec. 2019;184(17):515. doi:10.1136/vr.l1896
Jarvis S. Is pet insurance sustainable? Vet Rec. 2019;184(7):210. doi:10.1136/vr.l721
Center for Outcomes Research and Epidemiology. College of Veterinary Medicine. Kansas State University. Accessed May 7, 2021. https://www.vet.k-state.edu/research/core/
Animal health – new kid on the HEOR block? The Professional Society for Health Economics and Outcomes Research. Accessed May 3, 2021. https://www.ispor.org/heor-resources/presentations-database/presentation/euro2019-3150/10816
Advertisement
Ellwood PM. Shattuck lecture—outcomes management. A technology of patient experience. N Engl J Med. 1988;318(23):1549–1556. doi:10.1056/NEJM198806093182327
Porter M, Lee TH. The strategy that will fix health care. Harvard Business Review. October 2013. Accessed September 16, 2021. https://hbr.org/2013/10/the-strategy-that-will-fix-health-care
Clancy CM, Eisenberg JM. Outcomes research: measuring the end results of health care. Science. 1998;282(5387):245–246. doi:10.1126/science.282.5387.245
US pet ownership and demographic sourcebook. 2017–2018 edition. AVMA. Accessed September 16, 2021. https://www.avma.org/sites/default/files/resources/AVMA-Pet-Demographics-Executive-Summary.pdf
Pet industry market size, trends & ownership statistics. American Pet Products Association. Accessed May 6, 2021. https://www.americanpetproducts.org/press_industrytrends.asp
Friedman E, Krause-Parello CA. Companion animals and human health: benefits, challenges, and the road ahead for human-animal interaction. Rev Sci Tech. 2018;37(1):71–82. doi:10.20506/rst.37.1.2741
Beetz A, Uvnäs-Moberg K, Julius H, Kotrschal K. Psychosocial and psychophysiological effects of human-animal interactions: the possible role of oxytocin. Front Psychol. 2012;3:234. doi:10.3389/fpsyg.2012.00234
Morgan L, Protopopova A, Dupont Birker RI, et al. Human-dog relationships during the COVID-19 pandemic: booming dog adoption during social isolation. Humanit Soc Sci Commun. 2020;7:155. doi:10.1057/s41599–020–00649-x
Ratschen E, Shoesmith E, Shahab L, et al. Human-animal relationships and interactions during the Covid-19 lockdown phase in the UK: investigating links with mental health and loneliness. PLoS One. 2020;15(9):e0239397. doi:10.1371/journal.pone.0239397
Are pet adoptions really skyrocketing? AVMA. Accessed May 6, 2021. https://www.avma.org/javma-news/2021–01–15/are-pet-adoptions-really-skyrocketing
Burgos Cáceres S. The roles of veterinarians in meeting the challenges of health and welfare of livestock and global food security. Vet Res Forum. 2012;3(3):155–157.
The roles of veterinarians in meeting the challenges of health and welfare of livestock and global food security. Animal Production and Health. Food and Agriculture Organization of the United Nations (FAO). Accessed May 5, 2021. www.fao.org/ag/againfo/home/en/news_archive/2011_The_roles_of_veterinarians.html
Lenarduzzi R, Sheppard GA, Slater MR. Factors influencing the choice of a career in food-animal practice among recent graduates and current students of Texas A&M University, College of Veterinary Medicine. J Vet Med Educ. 2009;36(1):7–15. doi:10.3138/jvme.36.1.7
Rural veterinary care. AVMA. Accessed June 3, 2021. https://www.avma.org/advocacy/rural-veterinary-care
Stull JW, Shelby JA, Bonnett BN, et al. Barriers and next steps to providing a spectrum of effective health care to companion animals. J Am Vet Med Assoc. 2018;253(11):1386–1389. doi:10.2460/javma.253.11.1386
Volk JO, Felsted KE, Thomas JG, Siren CW. Executive summary of the Bayer veterinary care usage study. J Am Vet Med Assoc. 2011;238(10):1275–1282. doi:10.2460/javma.238.10.1275
Kipperman BS, Kass PH, Rishniw M. Factors that influence small animal veterinarians’ opinions and actions regarding cost of care and effects of economic limitations on patient care and outcome and professional career satisfaction and burnout. J Am Vet Med Assoc. 2017;250(7):785–794. doi:10.2460/javma.250.7.785
Coe JB, Adams CL, Bonnett BN. A focus group study of veterinarians’ and pet owners’ perceptions of the monetary aspects of veterinary care. J Am Vet Med Assoc. 2007;231(10):1510–1518. doi:10.2460/javma.231.10.1510
Jensen KL, English BC, Menard RJ, Holland RE. Livestock producers’ views on accessing food-animal veterinary services: implications for student recruitment, training, and practice management. J Vet Med Educ. 2009;36(1):30–38. doi:10.3138/jvme.36.1.30
Pires AFA, Peterson A, Baron JN, Adams R, Martínez-López B, Moore D. Small-scale and backyard livestock owners needs assessment in the western United States. PLoS One. 2019;14(2):e0212372. doi:10.1371/journal.pone.0212372
Jefford M, Stockler MR, Tattersall MHN. Outcomes research: what is it and why does it matter? Intern Med J. 2003;33(3):110–118. doi:10.1046/j.1445-5994.2003.00302.x
Karakiewicz PI, Briganti A, Chun FKH, Valiquette L. Outcomes research: a methodologic review. Eur Urol. 2006;50(2):218–224. doi:10.1016/j.eururo.2006.05.009
Poulsen Nautrup B, Van Vlaenderen I. Cost-effectiveness of Pimobendan versus Benazepril in acquired myxomatous mitral valve disease in dogs: an adaptation to Switzerland. Value Health. 2009;12(3):A62. Abstract.
Van Vlaenderen I, Nautrup BP, Gasper SM. Estimation of the clinical and economic consequences of non-compliance with antimicrobial treatment of canine skin infections. Prev Vet Med. 2011;99(2-4):201–210. doi:10.1016/j.prevetmed.2011.01.006
Reid J, Wiseman-Orr ML, Scott EM, Nolan AM. Development, validation and reliability of a web-based questionnaire to measure health-related quality of life in dogs. J Small Anim Pract. 2013;54(5):227–233. doi:10.1111/jsap.12059
Wright A, Amodie D, Cernicchiaro N, Lascelles B, Pavlock A. Diagnosis and treatment rates of osteoarthritis in dogs using a health risk assessment (HRA) or health questionnaire for osteoarthritis in general veterinary practice. Value Health. 2019;22(2):S387. doi:10.1016/j.jval.2019.04.1886
Tonsor GT, Schroeder TC. Market impacts of E. coli vaccination in US feedlot cattle. Agric Food Econ. 2015;3(7):1–15. doi:10.1186/s40100-014-0021-2
Benedictus A, Hogeveen H, Berends BR. The price of the precautionary principle: cost-effectiveness of BSE intervention strategies in the Netherlands. Prev Vet Med. 2009;89(3-4):212–222. doi:10.1016/j.prevetmed.2009.03.001
Suijkerbuijk AWM, van Gils PF, Bonačić Marinović AA, et al. The design of a social cost-benefit analysis of preventive interventions for toxoplasmosis: an example of the One Health approach. Zoonoses Public Health. 2018;65(1):185–194. doi:10.1111/zph.12417
Mangen MJJ, de Wit GA, Havelaar AH. Economic analysis of Campylobacter control in the Dutch broiler meat chain. Agribusiness. 2007;23(2):173–192. doi:10.1002/agr.20123
Barratt AS, Rich KM, Eze JI, Porphyre T, Gunn GJ, Stott AW. Framework for estimating indirect costs in animal health using time series analysis. Front Vet Sci. 2019;6(120):190. doi:10.3389/fvets.2019.00190
McReynolds SW, Sanderson MW, Reeves A, Hill AE. Modeling the impact of vaccination control strategies of a foot and mouth disease outbreak in the Central United States. Prev Vet Med. 2014;117(3–4):487–504. doi:10.1016/j.prevetmed.2014.10.005
Schroeder TC, Pendell DL, Sanderson MW, McReynolds S. Economic impact of alternative FMD emergency vaccination strategies in the Midwestern United States. J Agric Appl Econ. 2015;47(1):47–76. doi:10.1017/aae.2014.5
Codman EA. The product of a hospital. 1914. Arch Pathol Lab Med. 1990;114(11):1106–1111.
Codman EA. The classic: a study in hospital efficiency: as demonstrated by the case report of first five years of private hospital. Clin Orthop Relat Res. 2013;471(6):1778–1783. doi:10.1007/s11999-012-2751-3
Donabedian A. Evaluating the quality of medical care. Milbank Q. 2005;83(4):691–729. doi:10.1111/j.1468-0009.2005.00397.x
Cochrane AL. Archie Cochrane in his own words. Selections arranged from his 1972 introduction to “Effectiveness and efficiency: random reflections on the health services”. Control Clin Trials. 1989;10(4):428–433. doi:10.1016/0197-2456(89)90008-1
Mission O. The Professional Society for Health Economics and Outcomes Research. Accessed September 16, 2021. https://www.ispor.org/about/our-mission.
Story O. Patient-Centered Outcomes Research Institute. Accessed September 16, 2021. https://www.pcori.org/about-us/our-story
Director’s Welcome. Center for Outcomes Research & Evaluation (CORE). Yale School of Medicine. Accessed September 16, 2021. https://medicine.yale.edu/core/about/
Center for Health Services and Outcomes Research. Johns Hopkins Bloomberg School of Public Health. Accessed May 7, 2021. www.jhsph.edu/research/centers-and-institutes/health-services-outcomes-research/
Krumholz HM. Outcomes research: generating evidence for best practice and policies. Circulation. 2008;118(3):309–318. doi:10.1161/CIRCULATIONAHA.107.690917
Spertus J, Lozada L, Jones P. Sustaining and disseminating the evidence. Abstract in: Proceedings of the Translational Medicine Meeting. BioNexus KC; 2016.
Karcher H, Fu S, Efthimiou O, Schneeweiss S, Abenhaim L. A practical guide to adding patient heterogeneity into phase III trials: results from IMI GetReal WP2. Abstract in: Proceedings of the International Society for Health Economics and Outcomes Research, Annual European Congress. Professional International Society for Health Economics and Outcomes Research; 2015.
Karcher H, Nordon C, Neumann M, et al. Methods to evaluate real-world effectiveness in pre-authorization trials: a systematic literature review for IMI GetReal WP2. Abstract in: Proceedings of the Health Technology Assessment International Annual Meeting. Health Technology Assessment International; 2015.
Shaw APM, Rushton J, Roth F, Torgerson PR. DALYs, dollars and dogs: how best to analyse the economics of controlling zoonoses. Rev Sci Tech. 2017;36(1):147–161. doi:10.20506/rst.36.1.2618
Torgerson PR, Rüegg S, Devleesschauwer B, et al. zDALY: an adjusted indicator to estimate the burden of zoonotic diseases. One Health. 2017;5:40–45. doi:10.1016/j.onehlt.2017.11.003
Lavan RP. Development and validation of a survey for quality of life assessment by owners of healthy dogs. Vet J. 2013;197(3):578–582. doi:10.1016/j.tvjl.2013.03.021
Belshaw Z, Asher L, Harvey ND, Dean RS. Quality of life assessment in domestic dogs: an evidence-based rapid review. Vet J. 2015;206(2):203–212. doi:10.1016/j.tvjl.2015.07.016
Mwacalimba KK, Contadini FM, Spofford N, et al. Owner and veterinarian perceptions about use of a canine quality of life survey in primary care settings. Front Vet Sci. 2020;7:89. doi:10.3389/fvets.2020.00089
Parker RA, Yeates JW. Assessment of quality of life in equine patients. Equine Vet J. 2012;44(2):244–249. doi:10.1111/j.2042-3306.2012.00583.x
Cook JL. Canine orthopedic outcome measures program: where are we now? Vet Surg. 2014;43(3):229–231. doi:10.1111/j.1532-950X.2014.12167.x
Giuffrida MA, Brown DC, Ellenberg SS, Farrar JT. Development and psychometric testing of the Canine Owner-Reported Quality of Life questionnaire, an instrument designed to measure quality of life in dogs with cancer. J Am Vet Med Assoc. 2018;252(9):1073–1083. doi:10.2460/javma.252.9.1073
Bowen J, Garcia E, Darder P, Arguelles J, Fatjo J. The effects of the Spanish COVID-19 lockdown on people, their pets, and the human-animal bond. J Vet Behav. 2020;40:75–91. doi:10.1016/j.jveb.2020.05.013
Piotti P, Karagiannis C, Satchell L, et al. Use of the Milan pet quality of life instrument (MPQL) to measure pets’ quality of life during COVID-19. Animals (Basel). 2021;11:1336. doi:10.3390/ani11051336
Wilson SJ, Ward MP, Garner MG. A framework for assessing the intangible impacts of emergency animal disease. Prev Vet Med. 2013;111:194–199. doi:10.1016/j.prevetmed.2013.05.003
Pantaleon L. Why measuring outcomes is important in health care. J Vet Intern Med. 2019;33:356–362. doi:10.1111/jvim.15458
Bouwer A. Analysis of survey data for learning effectiveness evaluation of a talent management program for dairies and feedlots. Abstract in: Proceedings of the International Society for Health Economics and Outcomes Research, Annual International Meeting. Professional International Society for Health Economics and Outcomes Research; 2015.
Bouwer A, Holland R, Walter S. Evaluation of audit scoring consistency in a comprehensive feedlot management system and correlation with feedyard performance based on average daily gain and dry feed conversation in 11 US feedlots. Abstract in: Proceedings of the International Society for Health Economics and Outcomes Research, Annual International Meeting. Professional International Society for Health Economics and Outcomes Research; 2015.
Falzon LC, Lechner I, Chantziaras I, et al. Quantitative outcomes of a one health approach to study global health challenges. EcoHealth. 2018;15(1):209–227. doi:10.1007/s10393-017-1310-5
Vellinga TV, de Haan MHA, Schils RLM, Evers A, van den Pol–van Dasselaar A. Implementation of GHG mitigation on intensive dairy farms: farmers’ preferences and variation in cost effectiveness. Livest Sci. 2011;137:185–195. doi:10.1016/j.livsci.2010.11.005
Wright A, Russo S, DiFranco B, Gasper S, Amodie D. Client acceptance trial with injectable cefovecin sodium in dogs as a first line of treatment for superficial pyoderma, wounds, and abscesses caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis group G. Abstract in: Proceedings of the International Society for Health Economics and Outcomes Research, Annual International Meeting. Professional International Society for Health Economics and Outcomes Research; 2015.
Widmar NO, Bir C, Slipchenko N, Wolf C, Hansen C, Ouedraogo F. Online procurement of pet supplies and willingness to pay for veterinary telemedicine. Prev Vet Med. 2020;181:105073. doi:10.1016/j.prevetmed.2020.105073
Depoorter P, Van Huffel X, Diricks H, et al. Measuring general animal health status: development of an animal health barometer. Prev Vet Med. 2015;118(4):341–350. doi:10.1016/j.prevetmed.2014.12.008
Poulsen Nautrup B, van Vlaenderen IV, Wright A, Holland R, Gasper S. Health and economic benefits of vaccinating horses against West Nile Virus in the USA. Abstract in: Proceedings of the 13th World Equine Veterinary Association Congress. World Equine Veterinary Association; 2013.
Abell KM, Theurer ME, Larson RL, White BJ, Apley M. A mixed treatment comparison meta-analysis of metaphylaxis treatments for bovine respiratory disease in beef cattle. J Anim Sci. 2017;95(2):626–635. doi:10.2527/jas.2016.1062
Cull CA, Paddock ZD, Nagaraja TG, Bello NM, Babcock AH, Renter DG. Efficacy of a vaccine and a direct-fed microbial against fecal shedding of Escherichia coli O157:H7 in a randomized pen-level field trial of commercial feedlot cattle. Vaccine. 2012;30(43):6210–6215. doi:10.1016/j.vaccine.2012.05.080
Cull CA, Renter DG, Bello NM, Ives SE, Babcock AH. Performance and carcass characteristics of commercial feedlot cattle from a study of vaccine and direct-fed microbial effects on Escherichia coli O157:H7 fecal shedding. J Anim Sci. 2015;93(6):3144–3151. doi:10.2527/jas.2015-8924
Dennis EJ, Schroeder TC, Renter DG, Pendell DL. Value of arrival metaphylaxis in US cattle industry. 2018. J Agric Resour Econ. 2018;43(2):233–250. doi:10.22004/ag.econ.273448
O’Connor AM, Yuan C, Cullen JN, Coetzee JF, da Silva N, Wang C. A mixed treatment meta-analysis of antibiotic treatment options for bovine respiratory disease—an update. Prev Vet Med. 2016;132:130–139. doi:10.1016/j.prevetmed.2016.07.003
Poulsen Nautrup B, Van Vlaenderen I, Decker M, Cleale RM. Antimicrobial drug use for control and treatment of bovine respiratory disease in US feedlot cattle: a meta-analysis of comparative studies versus tulathromycin. Bovine Pract. 2017;51(1):1–13. doi:10.21423/bovine-vol51no1p1-13
Roth F, Zinsstag J, Orkhon D, et al. Human health benefits from livestock vaccination for brucellosis: case study. Bull World Health Organ. 2003;81(12):867–876.
Babo Martins S, Rushton J. Cost-effectiveness analysis: adding value to assessment of animal health, welfare and production. Rev Sci Tech. 2014;33(3):681–689. doi:10.20506/rst.33.3.2312
Bergevoet RH, van Schaik G, Veling J, Backus GBC, Franken P. Economic and epidemiological evaluation of Salmonella control in Dutch dairy herds. Prev Vet Med. 2009;89(1-2):1–7. doi:10.1016/j.prevetmed.2008.12.007
Lawson LG, Jensen JD, Christiansen P, Lund M. Cost-effectiveness of Salmonella reduction in Danish abattoirs. Int J Food Microbiol. 2009;134(1-2):126–132. doi:10.1016/j.ijfoodmicro.2009.03.024
Simons R, Hill A, de Souza Monteiro D, Fraser R, Cook A. A cost-effectiveness analysis for Salmonella interventions in the British pig meat production chain. Abstract in: Proceedings of the International Symposium on the Epidemiology and Control of Biological, Chemical and Physical Hazards in the Pork Chain. MCI Deutschland GmbH; 2009.
Pillars RB, Grooms DL, Wolf CA, Kaneene JB. Economic evaluation of Johne’s disease control programs implemented on six Michigan dairy farms. Prev Vet Med. 2009;90(3-4):223–232. doi:10.1016/j.prevetmed.2009.04.009
Martínez-López B, Carpenter TE, Sánchez-Vizcaíno JM. Risk assessment and cost-effectiveness analysis of Aujeszky’s disease virus introduction through breeding and fattening pig movements into Spain. Prev Vet Med. 2009;90(1-2):10–16. doi:10.1016/j.prevetmed.2009.03.004
De Vos CJ, Saatkamp HW, Huirne RB. Cost-effectiveness of measures to prevent classical swine fever introduction into the Netherlands. Prev Vet Med. 2005;70(3-4):235–256. doi:10.1016/j.prevetmed.2005.04.001
Knight-Jones TJ, Hauser R, Matthes D, Stärk KDC. Evaluation of effectiveness and efficiency of wild bird surveillance for avian influenza. Vet Res. 2010;41(4):50. doi:10.1051/vetres/2010023
Hadorn D, Racloz V, Schwermer H, Stärk KDC. Establishing a cost-effective national surveillance system for Bluetongue using scenario tree modelling. Vet Res. 2009;40(6):1–14. doi:10.1051/vetres/2009040
Regula G, Lo Fo Wong DM, Ledergerber U, et al. Evaluation of an antimicrobial resistance monitoring program for Campylobacter in poultry by simulation. Prev Vet Med. 2005;70(1-2):29–43. doi:10.1016/j.prevetmed.2005.02.017
Telemedicine. AVMA. Accessed August 6, 2021. https://www.avma.org/resources-tools/avma-policies/telemedicine
Cleaveland S, Kaare M, Knobel D, Laurenson MK. Canine vaccination—providing broader benefits for disease control. Vet Microbiol. 2006;5(117-1):43–50. doi:10.1016/j.vetmic.2006.04.009
Kaare M, Lembo T, Hampson K, et al. Rabies control in rural Africa: evaluating strategies for effective domestic dog vaccination. Vaccine. 2009;27(1):152–160. doi:10.1016/j.vaccine.2008.09.054
Beyene TJ, Fitzpatrick M, Galvani AP, et al. Impact of One-Health framework on vaccination cost-effectiveness: a case study of rabies in Ethiopia. One Health. 2019;8:100103. doi:10.1016/j.onehlt.2019.100103
Okello WO, Okello AL, Inthavong P, et al. Improved methods to capture the total societal benefits of zoonotic disease control: demonstrating the cost-effectiveness of an integrated control programme for Taenia solium, soil transmitted helminths and classical swine fever in northern Lao PDR. PLoS Negl Trop Dis. 2018;12(9):e0006782. doi:10.1371/journal.pntd.0006782
Taylor D. The pharmaceutical industry and the future of drug development. In: Hester RE, Harrison RM, eds. Pharmaceuticals in the Environment. Royal Society of Chemistry; 2015:1–33. doi:10.1039/9781782622345–00001
Sullivan SD, Manuskopf JA, Augustovski F, et al. Budget impact analysis—principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value Health. 2014;17(1):5–14. doi:10.1016/j.jval.2013.08.2291
Sørensen J, Andersen LS. The case of tumour necrosis factor-α inhibitors in the treatment of rheumatoid arthritis—a budget impact analysis. Pharmacoeconomics. 2005;23(3):289–298. doi:10.2165/00019053-200523030-00008
Nuijten MJC, Rutten F. Combining a budgetary-impact analysis and a cost-effectiveness analysis using decision-analytic modelling techniques. Pharmacoeconomics. 2002;20(12):855–867. doi:10.2165/00019053-200220120-00006
National Institute for Health and Care Excellence (NICE). Accessed May 7, 2021. https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/chte-methods-consultation
Basu A. Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care. J Health Econ. 2011;30(3):549–559. doi:10.1016/j.jhealeco.2011.03.004
Karcher H, Bradbury C, Mozaffari E, et al. Drivers of effectiveness for informed outcomes-based agreements. Abstract in: Proceedings of the International Society for Health Economics and Outcomes Research, Annual International Meeting. Professional International Society for Health Economics and Outcomes Research; 2016.
Top10 HEOR trends. International Society for Pharmacoeconomics and Outcomes Research. Accessed May 7, 2020. https://www.ispor.org/docs/default-source/heor-resources/2020-top-10-heor-trendsv-online_00120191219.pdf?sfvrsn=9eebcb74_0
Industry data. North American Pet Health Insurance Association (NAPHIA). Accessed May 7, 2021. https://naphia.org/industry-data/
Ross K. Pet insurance for all: Sweden’s experience. Accessed August 6, 2021. https://news.vin.com/default.aspx?pid=210&Id=9305364
Mills G. New highs for pet insurance market. Vet Rec. 2019;184(17):515. doi:10.1136/vr.l1896
Jarvis S. Is pet insurance sustainable? Vet Rec. 2019;184(7):210. doi:10.1136/vr.l721
Center for Outcomes Research and Epidemiology. College of Veterinary Medicine. Kansas State University. Accessed May 7, 2021. https://www.vet.k-state.edu/research/core/
Animal health – new kid on the HEOR block? The Professional Society for Health Economics and Outcomes Research. Accessed May 3, 2021. https://www.ispor.org/heor-resources/presentations-database/presentation/euro2019-3150/10816
Advertisement